Long-Term Safety and Clinical Outcomes with Insulin Degludec/Insulin Aspart Treatment in Japanese Patients with Diabetes: A Real-World, Prospective, Observational Study

INTRODUCTION: Insulin degludec/insulin aspart (IDegAsp) provides effective glycaemic control with an acceptable safety profile in Japanese patients with diabetes in randomised clinical trials. This post-marketing surveillance study assessed long-term safety and clinical outcomes with IDegAsp in a Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Katabami, Takuyuki, Eriksen, Kirsten T., Yamamoto, Yuiko, Ishigaki, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799571/
https://www.ncbi.nlm.nih.gov/pubmed/34800283
http://dx.doi.org/10.1007/s12325-021-01978-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799571/
https://www.ncbi.nlm.nih.gov/pubmed/34800283
http://dx.doi.org/10.1007/s12325-021-01978-2

Ejemplares similares